跳轉至內容
Merck
全部照片(1)

重要文件

566405

Sigma-Aldrich

SIS3

≥90% (HPLC), solid, Smad3 inhibitor, Calbiochem®

同義詞:

Smad3抑制剂,SIS3

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C28H27N3O3
CAS號碼:
分子量::
453.53
MDL號碼:
分類程式碼代碼:
12352200
NACRES:
NA.28
暫時無法取得訂價和供貨情況

產品名稱

Smad3抑制剂,SIS3, Smad3 Inhibitor, SIS3, CAS 1009104-85-1, is a cell-permeable, selective inhibitor of TGF-β1-dependent Smad3 phosphorylation and Smad3-mediated signaling. Does not affect Smad2, MAPK, ERK, or PI3-K.

品質等級

化驗

≥90% (HPLC)

形狀

solid

製造商/商標名

Calbiochem®

儲存條件

OK to freeze
protect from light

顏色

off-white

溶解度

DMSO: 15 mg/mL
ethanol: 5 mg/mL

運輸包裝

ambient

儲存溫度

2-8°C

SMILES 字串

[n]1(c2ncccc2c(c1c5ccccc5)C=CC(=O)N3CCc4c(cc(c(c4)OC)OC)C3)C

InChI

1S/C28H27N3O3/c1-30-27(19-8-5-4-6-9-19)22(23-10-7-14-29-28(23)30)11-12-26(32)31-15-13-20-16-24(33-2)25(34-3)17-21(20)18-31/h4-12,14,16-17H,13,15,18H2,1-3H3

InChI 密鑰

IJYPHMXWKKKHGT-UHFFFAOYSA-N

應用

Smad3(SIS3)的特异性抑制剂已被用于阻断转化生长因子(TGF)-β/母体十肽同系物3 (SMAD3)信号转导,以表征肺成纤维细胞中有助于信号转导子和转录激活子3(STAT3)活化的信号转导途径 。[1]它也可用作无血清培养基中的SMAD3 抑制剂,用于评估其预防ARPE-19细胞中丙烯醛作用的能力。[2]

生化/生理作用

Smad3(SIS3)的特异性抑制剂是一种吡咯并吡啶化合物。[3]它选择性阻断转化生长因子(TGF)-β1-依赖型母体十肽同系物3 (Smad3) 磷酸化和Smad3介导的细胞途径,但是不影响Smad2, p38分裂素活化的蛋白质激酶(MAPK)、胞外信号调节激酶(ERK)或磷酸肌醇3-激酶(PI3K)信号传导。 [4][3] 通过其抑制功能, SIS3调节小鼠单侧输尿管梗阻(UUO)肾的纤维化、细胞凋亡和炎症。因此,SIS3可用作肾病抗纤维化治疗的有效药物。[5]
主要靶标
TGF-β1依赖性Smad3磷酸化和Smad3介导的细胞信号转导

包裝

用惰性气体包装

警告

毒性:刺激性(B)

重構

复溶后,等分并冷冻保存(-20°C)。贮备溶液在-20°C下可稳定保存至多3个月。

其他說明

可逆:否
产物不与ATP竞争。
细胞可渗透性:是
Jinnin, M., et al. 2006.Mol.Pharmacol.69, 597.

法律資訊

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 1

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Xingli Ji et al.
Medical science monitor : international medical journal of experimental and clinical research, 24, 1633-1641 (2018-03-21)
BACKGROUND Fibrosis is the common pathological feature in most kinds of chronic kidney disease (CKD). TGF-β/Smads signaling is the master pathway regulating kidney fibrosis pathogenesis, in which Smad3 acts as the integrator of various pro-fibrosis signals. In this study, we
Jeffery Grigsby et al.
Current eye research, 37(11), 1045-1053 (2012-08-22)
Acrolein has been implicated in retinal pigment epithelium (RPE) cell death, and has been associated with diabetic retinopathy. Our purpose was to investigate the potential effect of high glucose in influencing acrolein-mediated RPE cytokine production and cell death. We investigated
Yi Luo et al.
Stem cell research & therapy, 15(1), 4-4 (2024-01-04)
TMC1 is one of the most common deafness genes causing DFNA36. Patient-derived human induced pluripotent stem cells (iPSCs) provide an opportunity to modelling diseases. TMC1 p.M418K mutation in human is orthologous to Beethoven mice. Here, we investigated the differentiation, morphology
Chaitali Chakraborty et al.
Nature communications, 14(1), 6446-6446 (2023-10-14)
Chromatin organization controls transcription by modulating 3D-interactions between enhancers and promoters in the nucleus. Alterations in epigenetic states and 3D-chromatin organization result in gene expression changes contributing to cancer. Here, we map the promoter-enhancer interactome and regulatory landscape of glioblastoma
Masatoshi Jinnin et al.
Molecular pharmacology, 69(2), 597-607 (2005-11-17)
This is the first report that characterizes specific inhibitor of Smad3 (SIS3) as a potent and selective inhibitor of Smad3 function. In the reporter assay, the increased luciferase activity of p3TP-lux by the overexpression of constitutively active form of ALK-5

Questions

Reviews

No rating value

Active Filters

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務